RestoredCDC.org Comparison

    Original site: www.cdc.gov/mmwr/preview/mmwrhtml/rr6104a2.htm | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
    [More]
    About Us Report Bug Compare Content
  Skip directly to search Skip directly to A to Z list Skip directly to site content
      CDC Home
          CDC 24/7: Saving Lives. Protecting People.™
            Search The CDC
        Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.
        Morbidity and Mortality Weekly Report (MMWR)
              * MMWR
              * 
              * 
              * 
              * 
              * 
              * Twitter
              * Facebook
              * LinkedIn
              * Email
              * Digg
              * Add this to your site
                  Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
                Appendix A: Conflicts of Interest
                  Recommendations and Reports
                  August 17, 2012 / 61(RR04);19-22
                    External Work Group Members         
                    Miriam Alter, PhD                   
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Sanjeev Arora, MD                   
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Consultancy:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Served on Advisory Board of Vertex Pharmaceuticals in 2009                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Grants/Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Grants from Vertex Pharmaceuticals, Roche/ Genentech, Gilead, Zyrnogenetics, Bristol Myers, Pharmasett, and Abbott paid to institution for clinical trials                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Lectures/ Speakers Bureaus:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                          Scherring Corp., served on September Bureau for Roche Pharmaceuticals until mid-2009                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                    Bruce Bacon, MD                     
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Doug Campos-Outcalt, MD             
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Alfred DeMaria, Jr., MD             
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Janet Durfee, MSN                   
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Yngve Falck-Ytter, MD               
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Colleen Flanigan, MS                
                                                          Support for Travel:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                    For the work under consideration:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                          CDC Foundation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Marc Ghany, MD                      
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Robert Gish, MD                     
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Board Membership:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                          Hepahope                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                          Consultancy:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Performed as a consultant to Abbott, Anadys Pharmaceuticals, Inc., Bayer AG, Bristol-Myers Squibb Company, Durect, Hepahope, Hoffman-LaRoche Ltd., Genentech, Gilead Sciences, GlaxoSmithKline, GlobeImmune, Human Genome Sciences, Merck, Metabasis Therapeutics, OSI/Astellas Parmasset, Schering-Plough Corporation, Three Rivers Pharma, VitalTherapies, and ZymoGenetics; payments directed to an SPF fund for research and education.                                                                                                                                                           
                                                          Lectures/ Speakers Bureaus:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Speakers bureau activities for Bayer, Bristol-Myers Squibb Company, F. Hoffman-LaRoche Ltd., Gilead Sciences, Inc., GlaxoSmithKline, Onyx, Merck/Schering-Plough Corporation, Three Rivers, Salix, SciClone Pharmaceuticals focused on HBV, HCV, and liver cancer, specifically epidemiology, diagnosis, and treatment, with additional program presentations for HBV and management of complications of cirrhosis; has a speakers contract to do promotional talks for BMS, Roche, Schering-Plough, Gilead Sciences, Bayer and Onyx; payments are directed to an SPF fund for research and education.
                                                          Grants/ Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                          Support from Bayer-Onyx, Bristol-Myers Squibb Company, Genentech/ F. Hoffman-LaRoche, Ltd., Gilead Sciences, Genentech, Pharmasset, Zymogenetics; payments directed to an institutional fund under contract to CPMC.                                                                                                                                                                                                                                                                                                                                                                                  
                                                          Stock/ Stock Options:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                          Major stock shareholder for Hepahope                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                    Fasiha Kanwal, MD                   
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Emmett Keeffe, MD                   
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Consultancy:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Vertex                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Travel/ Accommodations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                          Vertex                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                    Kathleen Koechlin, PhD              
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Cameron Lewis                       
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Jake Liang, MD                      
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Robert Lubran, MPA                  
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Iris Mabry-Hernandez, MD            
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Katherine McGlynn, PhD              
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Barbara McGovern, MD                
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Employment:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                          Editor at UpToDate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Other:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                          Editor at Infectious Diseases Society of America                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                    Rachel McLean, MPH                  
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Michael Ninburg                     
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Consultancy:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Vertex, Abbott, Genentech, GlaxoSmithKline, Merck, Hoffman LaRoche, Tibotec, Boehringer Ingelheim                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                          Grants/ Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Grants from Vertex, Merck, Genentech, Hoffman La Roche, Schering Plough, Gilead, Novartis, and Human Genome Sciences paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                          Payment for the Development of Educational Presentations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                          Vertex, Hoffmann La Roche, and Schering Plough, paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                    Phillip Reichert, MPH               
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Vinod Rustgi, MD                    
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Consultancy:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Merck, Vertex                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                          Grants/ Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Grants from BMS, Gilead, Anadys, Boehringer-Ingelheim-Abbott paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                          Lectures/ Speakers Bureaus:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                          Merck, Vertex, Genentech, Gilead, Onyx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                    Lorren Sandt                        
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Consultancy:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Abbott, for community advisory board and paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Grants/ Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Unrestricted educational grants from Vertex, Merck, and Genentech paid to institution; Conference grant from Gilead paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                          Travel/ Accommodations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                          Money for travel from BMS, Vertex, Boehringer Ingelheim, Merck, Genentech/Roche and Tibotec for community advisory boards and paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                    Gloria Searson                      
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Anne Spaulding, MD                  
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Consultancy:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Georgia Correctional Healthcare; clinical consultant for hepatitis and HIV care                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                          Grants/ Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Grant support from DHHS, CDC, HRSA, and indirectly from NIH paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                          Lectures/ Speakers Bureaus:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                          Hepatitis Foundation International, Albany Medical College                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Donna Sweet, MD                     
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Grants/ Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                          Pfizer, BMS Pharmaceuticals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Lectures/ Speakers Bureaus:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                          Abbott, BMS, Boehringer Ingelheim, Tibotec, Gilead                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                    Andrew Talal, MD                    
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Board Membership:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                          Merck & Co., Genentech/Roche, Boehringer Ingelheim, Pfizer, Bayer/ Onyx, Vertex                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                          Consultancy:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                          Merck & Co., Genentech                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                          Grants/ Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Merck & Co., Vertex, Boehringer-Ingelheim, and Genentech/Roche, Pfizer, Bayer/Onyx paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                          Lectures/ Speakers Bureaus:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                          Vertex and Genentech/ Roche                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                          Payment for Development of Educational Presentations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                          Merck & Co., Medscape                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                    Litjen Tan, PhD                     
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Chris Taylor                        
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Grants/ Grants Pending:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                          Vertex, Gilead, OraSure, Merck & Co., Janssen, BMS paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          Travel/ Accommodations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                          Vertex, OraSure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                    Lisa Townshend-Bulson, MSN          
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                          Expert Testimony:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                    Other relevant financial activities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                          CDC Cooperative Agreement with ANTHC, paid to institution                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                    Tam Van                             
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Kathleen Whitaker, PhD              
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Richard Wild, MD                    
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    John Wong, MD                       
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    CDC Work Group Members              
                    Geoff Beckett, MPH                  
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Scott Holmberg, MD                  
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Deborah Holtzman, PhD               
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Rebecca Morgan, MPH                 
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Dan Riedford, JD                    
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Bryce Smith, PhD                    
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Philip Spradling, MD                
                    For the work under cocnsideration:    No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Chong-Gee Teo, MD                   
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    John W. Ward, MD                    
                    For the work under consideration:     No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                    Other relevant financial activities:  No financial conflict of interest reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
                References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
              All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
              **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
            MMWR Home
              * Publications
                  + Weekly Report
                      o Past Volumes (1982-2014)
                  + Recommendations and Reports
                      o Past Volumes (1990-2014)
                  + Surveillance Summaries
                      o Past Volumes (1983-2014)
                  + Supplements
                  + Notifiable Diseases
              * About MMWR
              * Instructions for Authors
                  + Serial Publications
                  + Weekly
                  + Continuing Education
              * Continuing Education
                  + Weekly Publications
                  + Serial Publications
              * State Health Statistics
              * MMWR Editorial Board
              * MMWR Staff
          File Formats Help:
            * 
            * 
            * 
            * 
            * 
            * 
            * 
            * 
          How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
              * Print
              * Updates
              * Subscribe
              * Listen
              * Download
            * Page last reviewed: August 17, 2012
            * Page last updated: August 17, 2012
            * Content source: Centers for Disease Control and Prevention
            * Home
            * A-Z Index
            * Policies
            * Using this Site
            * Link to Us
            * Contact CDC
          Centers for Disease Control and Prevention 1600 Clifton Road Atlanta, GA 30329-4027, USA
          800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
        A-Z Index
         1. A
         2. B
         3. C
         4. D
         5. E
         6. F
         7. G
         8. H
         9. I
        10. J
        11. K
        12. L
        13. M
        14. N
        15. O
        16. P
        17. Q
        18. R
        19. S
        20. T
        21. U
        22. V
        23. W
        24. X
        25. Y
        26. Z
        27. #